Two Novel Mutations in the Argininosuccinate Lyase Gene in Iranian Patients and Literature Review

AuthorParastoo Rostamien
AuthorJohannes Häberleen
AuthorArya Setoudehen
AuthorJohannes Zschockeen
AuthorFatemeh Sayarifarden
Issued Date2017-06-30en
AbstractIntroduction: The argininosuccinate lyase (ASL) gene encodes argininosuccinate lyase (ASL), which is one of the six enzymes of the urea cycle that detoxifies blood ammonia. Argininosuccinate lyase deficiency impairs the function of the urea cycle and causes hyperammonemia, neurodevelopmental delay and hepatopathy. Case Presentation: Here we report two patients with argininosuccinate aciduria. They were treated with peritoneal dialysis and scavenger drugs. Molecular genetic testing showed two novel homozygous mutations, c.146T > G (p.Leu49Arg) in exon 3 and c.1144-1G > C in intron 15 of the ASL gene. Conclusions: This report intends to underline the importance of pediatricians being aware of the existence of a metabolic disease in any ill neonate. Diagnosis of urea cycle disorders is particularly important because of availability of effective treatment options.en
DOIhttps://doi.org/10.5812/ijp.7666en
KeywordHyperammonemiaen
KeywordArgininosuccinate Lyaseen
KeywordArgininosuccinic Aciduriaen
KeywordUrea Cycleen
PublisherBrieflandsen
TitleTwo Novel Mutations in the Argininosuccinate Lyase Gene in Iranian Patients and Literature Reviewen
TypeCase Reporten

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijp-27-03-7666.pdf
Size:
97.4 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF